Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Terminated 2

Sponsor Class

OTHER 4INDUSTRY 3NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Melanoma 49Breast Neoplasms 47Neoplasms 39Leukemia, Lymphocytic, Chronic, B-Cell 37Carcinoma, Non-Small-Cell Lung 36Neoplasm Metastasis 29Lymphoma, Large B-Cell, Diffuse 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Brain Neoplasms 24Lymphoma, Follicular 23Lung Neoplasms 23Colonic Neoplasms 23Rectal Neoplasms 22Carcinoma, Renal Cell 22Lymphoma, Non-Hodgkin 21Prostatic Neoplasms 20Glioblastoma 20Leukemia, Myeloid, Acute 19Kidney Neoplasms 19Pancreatic Neoplasms 18Lymphoma, B-Cell, Marginal Zone 18Lymphoma, Mantle-Cell 17Gliosarcoma 17Burkitt Lymphoma 17Sarcoma 16Multiple Myeloma 16Waldenstrom Macroglobulinemia 15Ovarian Neoplasms 15Esophageal Neoplasms 15Lymphoma 14

Interventions

Pioglitazone 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NIH × Inflammation × Clear all
NCT00031551 2017-12-06

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
27 enrolled 10 charts

Inflammation, Neoplasms, Stomatitis

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Terminated
1 enrolled

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡